Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Curriculum updated on 08/01/2012
-
Buprenorphine FAQ and Peer Discussion
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
Curriculum updated on 09/05/2012 -
Clinical Aspects of Buprenorphine Therapy
In this webinar, clinicians from two Ryan White clinics with successful buprenorphine programs describe what buprenorphine is and how it works.Resource updated 05/15/2024
-
Outpatient Ambulatory Medical Care and Laboratory Service Review Tool
Tool for service and program monitoring.
Resource updated 09/19/2023
-
Outpatient Ambulatory Medical Care Service Review
This resource is a tool for service and program monitoring.
Resource updated 09/19/2023
-
Outpatient and Ambulatory Medical Care Laboratory Program Review
Tool for service and program monitoring.
Resource updated 09/19/2023
-
Outpatient and Ambulatory Medical Care Program Review
Tool for service and program monitoring.
Resource updated 09/19/2023
-
Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs
CPAPA is no longer being updated by NASTAD and has been replaced by Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs.
Resource updated 10/31/2023
-
HIV/AIDS Guidelines
Federal guidelines for treatment, prevention and care of HIV disease, opportunistic infections, and common co-infections.
Resource updated 09/19/2023
-
HRSA HAB Notice of Funding Opportunity (NOFO) Announcements
Pre-application webinars for Notice of Funding Opportunity (NOFO) announcements from HRSA's HIV/AIDS Bureau for the Ryan White HIV/AIDS Program (RWHAP).
Resource updated 03/07/2024
-
PrEP Policies and Programs Help End the HIV Epidemic
Summary of pre-exposure prophylaxis (PrEP) provisions under HRSA and the Ryan White HIV/AIDS Program and PrEP resources on coverage and costs and providers with PrEP expertise.
Blog updated 11/14/2023
-
Hepatitis Testing Day
Millions of Americans have chronic viral hepatitis; most of them do not know they are infected. Hepatitis Testing Day, first observed in 2012, was designated as a national observance in the Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis as part of broader efforts to raise awareness of the silent epidemic of viral hepatitis in the United States.
Event updated 07/17/2024
-
Best Practices Compilation Continues to Grow
The Best Practices Compilation of tested HIV care interventions has added a new set of project innovations.Blog updated 07/23/2024
-
Few Get Needed Opioid Use Disorder Treatments
Only a small percentage of people in the U.S. with opioid use disorder (OUD) are receiving needed treatments.News Article updated on 07/18/2024 -
Southern Nevada Rapid stART
Southern Nevada Rapid stART improves access to immediate prescription of ART in the region. Led by the Office of HIV within Clark County Social Service, Rapid stART was initially developed and implemented at 28 sites to link clients to a prescribing HIV provider within seven days of their HIV diagnosis, and included a Rapid stART Response Team to support clients through the process. The Rapid stART program has increased linkage to HIV medical care, initiation of ART within seven days, and viral suppression.Resource from the RWHAP Best Practices Compilation updated on 07/24/2024
-
HIV Clinical Pharmacist Services
The HIV Clinical Pharmacist Services intervention shortens the time between referral to and engagement in care by allowing newly referred clients to see pharmacists in addition to other clinical providers for their initial appointment. This intervention is supported by findings from a retrospective cohort study that took place from 2013 to 2017 at a RWHAP-funded clinic. In addition to significantly decreasing the time between referral and initial visit, clients who saw a pharmacist also experienced shortened time to antiretroviral therapy initiation and viral suppression compared to those who only saw non-pharmacist providers.Resource from the RWHAP Best Practices Compilation updated on 07/29/2024